| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2005 | CN1196482C Use of anticonvulsant derivatives for treating bulimia nervosa |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196480C Application of calcium L-threonate in preparting drug of curing or preventing fracture |
| 04/13/2005 | CN1196479C Use of benzidine prostaglandins of inhalation form |
| 04/13/2005 | CN1196478C Combinations of formoterol and mometasone furoate for asthma |
| 04/13/2005 | CN1196477C Pharmaceutical compsition for oral delivery |
| 04/13/2005 | CN1196475C Bioavailable dosage form of isotretinoin |
| 04/13/2005 | CN1196406C Two-component and three-component fungicide compound |
| 04/12/2005 | US6879754 Drop-before-add optical switching and routing system employing grating-based wavelength selective switches |
| 04/12/2005 | US6878844 Synthesis of acyclic nucleoside derivatives |
| 04/12/2005 | US6878834 Selectively reduced to the corresponding hydroxy group |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/12/2005 | US6878823 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders |
| 04/12/2005 | US6878819 Oligosaccharides or oligosaccharide containing compounds, especially N-acetyl-chitooligosaccharides, which are fucosylated with donar nucleotide sugar containing L-fucose such as guanosine diphosphate-L-fucose |
| 04/12/2005 | US6878751 Administration of resveratrol to treat inflammatory respiratory disorders |
| 04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/12/2005 | US6878749 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/12/2005 | US6878748 Antiarrhythmic agents; myocardial infarction prophylaxis and treatment; angina pectoris treatment |
| 04/12/2005 | US6878747 Systemic formulations containing beta-carotene and derivatives thereof |
| 04/12/2005 | US6878746 Treating cancer |
| 04/12/2005 | US6878745 Selective preventives/remedies for progressive lesions after organ damage |
| 04/12/2005 | US6878744 Vitamin C compositions |
| 04/12/2005 | US6878742 Alzheimer's disease; Down's syndrome |
| 04/12/2005 | US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
| 04/12/2005 | US6878738 E.g., 2-(2-(4-Chlorophenyl)-6-hydroxymethyl-6-methyl-1-phenyl-6,7- dihydro-5H-pyrrolizin-3-yl)acetic acid; inhibition of 5-lipoxygenase and cyclooxygenase |
| 04/12/2005 | US6878736 Histamine H3 receptor ligands |
| 04/12/2005 | US6878734 Gastrin and cholecystokinin receptor ligands(II) |
| 04/12/2005 | US6878733 3-(pyrrol-2-ylvinyl)indolinones with polar groups, e.g.,3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethy l)- 1H-pyrrol-3-yl)-propionic acid with polyoxyhydrocarbyl compounds; protein kinase inhibitors |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878729 Antihypoxic agents |
| 04/12/2005 | US6878728 Sulfonamides containing a tetrahydrofurodihydrofuranyl-O-carbonylamino group; particularly for treating HIV viral infections |
| 04/12/2005 | US6878727 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878722 Substituted cycloalkyl P1′ hepatitis C virus inhibitors |
| 04/12/2005 | US6878721 Beta2-adrenoceptor agonists |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878717 HIV replication inhibiting pyrimidines |
| 04/12/2005 | US6878716 Compounds specific to adenosine A1 receptor and uses thereof |
| 04/12/2005 | US6878715 Xanthine derivatives such as 1-(5-N,N-dimethylaminohexyl)-3,7-dimethylxanthine |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878713 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 04/12/2005 | US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 04/12/2005 | US6878705 Especially agents against viruses of the herpes family. |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | US6878703 Mixture with diuretics; hypotensive agents |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/12/2005 | US6878699 Taccalonolide microtubule stabilizing agents |
| 04/12/2005 | US6878698 Anti-inflammatory androstane derivatives |
| 04/12/2005 | US6878694 Ophthalmic irrigating solution adapted for use in lasik surgery |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | US6878547 Antisense oligonucleotides against tenascin for treating vitiligo |
| 04/12/2005 | US6878541 Papilloma pseudo-virus and preparation |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | US6878514 Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
| 04/12/2005 | US6878388 Vanadium compounds for treating proliferative cell disorders |
| 04/12/2005 | US6878387 Core with an organic acid salt; acrylic blend coating of an interpolymer of a (meth)acrylate ester and a quaternary ammonium (meth)acrylate and a (meth)acrylate ester homo- or copolymer with an ester having acid or base groups |
| 04/12/2005 | US6878386 Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| 04/12/2005 | US6878369 Methods for treating urinary incontinence in mammals |
| 04/12/2005 | US6878365 Topical application for treating toenail fungus |
| 04/12/2005 | US6877565 Arrangement for the removal of cuttings and gas arising from drilling operations |
| 04/12/2005 | US6877514 Organ transplantation; administering a relatively large number of stem cells, combined with the creation of thymic space without the need for whole body irradiation; mixed chimerism can be formed without hematopoietic space-creating irradiation |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2362336C Anticonvulsant derivatives useful in treating essential tremor |
| 04/12/2005 | CA2356065C Phenoxyphenylheterocycle derivatives as ssris |
| 04/12/2005 | CA2322658C Process for synthesizing carbapenem antibiotics |
| 04/12/2005 | CA2293247C 4-phenylpiperidine compounds |
| 04/12/2005 | CA2252576C Use of dipeptidyl peptidase iv inhibitors for lowering the blood glucose level in mammals |
| 04/12/2005 | CA2250704C Glial cell line-derived neurotrophic factor receptor |
| 04/12/2005 | CA2235041C Iodine complexes in powder form |
| 04/12/2005 | CA2229316C Calcitriol derivatives and their uses |
| 04/12/2005 | CA2214665C Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/12/2005 | CA2179180C Depth-type filter for killing microorganisms and inactivating viruses and its use |
| 04/12/2005 | CA2178783C Zilpaterol chlorhydrate with a specific cristalline structure, process for preparing the same and intermediates used therefor |
| 04/12/2005 | CA2174107C Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 04/12/2005 | CA2142445C Injection solutions of azosemide which are ready for injection |
| 04/12/2005 | CA2137961C Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites |
| 04/12/2005 | CA2131229C Bisconjugates comprising two saccharides and a spacer |
| 04/12/2005 | CA2128380C 4-aryloxy- and 4-arylthiopiperidine derivatives |
| 04/12/2005 | CA2127193C 2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl] thio-carbapenem derivatives |
| 04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/10/2005 | CA2702138A1 Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 04/10/2005 | CA2444839A1 Ambroxol for the treatment of inflammation in the pharynx |